Lyon, France

Lucyna Cova

This inventor holds 1 USPTO granted patent. Top assignees: Instytut Biochemii I Biofizyki, Instytut Medycyny Doswiadczalnej I Kliniczne, National Institute of Health and Medical Research. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lucyna Cova. Retrieved from https://idiyas.com/inventor/lucyna-cova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lucyna Cova: Innovator in Pharmaceutical Applications

Introduction

Lucyna Cova is a notable inventor based in Lyons, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug derivatives. Her work focuses on improving medicinal applications and enhancing treatment options for various health conditions.

Latest Patents

Lucyna Cova holds one patent titled "Derivatives of epirubicin, their medicinal application and pharmaceutically acceptable forms of drugs." This invention relates to innovative derivatives of epirubicin, a well-known chemotherapy drug. The patent outlines pharmaceutical compositions that include these derivatives and their applications in treating Hepatitis C Virus (HCV).

Career Highlights

Throughout her career, Lucyna has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics and the National Institute of Health and Medical Research. Her experience in these organizations has allowed her to contribute to significant advancements in pharmaceutical research.

Collaborations

Lucyna has collaborated with notable colleagues, including Tadeusz Kulikowski and Maria Bretner. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.

Conclusion

Lucyna Cova's contributions to pharmaceutical innovations, particularly through her patent on epirubicin derivatives, highlight her role as a key inventor in the industry. Her work continues to influence the development of effective treatments for HCV and showcases the importance of research in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…